Compare
QTREX Quantum Ltd. vs Family Office of America, Inc. vs Co-Diagnostics, Inc. vs Sintx Technologies, Inc.
| Latest fiscal year | QTREX Quantum Ltd. QTEX | Family Office of America, Inc. FOFA | Co-Diagnostics, Inc. CODX | Sintx Technologies, Inc. SINT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $289.0K | $221.8K | $622.5K | $1.02M |
| Revenue growth (YoY) | n/a | n/a | -84.1% | -64.7% |
| Gross margin | 0.7% | 100.0% | 64.3% | 45.3% |
| Operating margin | n/m | -226.0% | n/m | n/m |
| Net margin | n/m | -222.2% | n/m | n/m |
| Net income | -$13.22M | -$492.7K | -$46.90M | -$10.36M |
| EPS (Diluted) | -$0.45 | -$0.02 | -$35.25 | -$6.16 |
| Operating cash flow | -$9.86M | -$262.2K | -$29.14M | -$8.57M |
| Free cash flow | -$9.96M | n/a | -$29.84M | -$8.76M |
| Cash & equivalents | $3.16M | n/a | $11.88M | $4.14M |
| Total assets | $5.34M | $1.54M | $24.74M | $9.51M |
| Total liabilities | n/a | $878.5K | $4.11M | $6.58M |
| Shareholders' equity | $2.32M | $664.5K | $20.63M | $2.93M |
| Return on year-end equity | -569.1% | -74.2% | -227.3% | -353.8% |
| Shares outstanding | 35.95M | 30.20M | 2.10M | 3.97M |
Revenue, most recent five fiscal years
| Fiscal year | QTREX Quantum Ltd. | Family Office of America, Inc. | Co-Diagnostics, Inc. | Sintx Technologies, Inc. |
|---|---|---|---|---|
| Latest | $289.0K Ended 2025-12-31 | $221.8K Ended 2025-12-31 | $622.5K Ended 2025-12-31 | $1.02M Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2024-12-31 | n/a | $3.92M Ended 2024-12-31 | $2.89M Ended 2024-12-31 |
| 2 years earlier | $0 Ended 2023-12-31 | n/a | $6.81M Ended 2023-12-31 | $2.63M Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $34.22M Ended 2022-12-31 | $1.56M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $97.89M Ended 2021-12-31 | $606.0K Ended 2021-12-31 |